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The split population model is a flexible way of extending the standard survival analytical 
methods to failure time data in which susceptibles and long-term survivors coexist. 
Susceptibles would develop the event with certainty if complete follow-up were 
possible, but the long-term survivors would never experience the event. 
A study was conducted to allow the effects of covariates on the probability that an 
individual is immune, and the immune probability vary from individual to individual. In 
effect, we are associating with each individual a distinct probability of being immune, 
which depends on the covariate information specific to that individual. And then fitted a 
few models using the maximum likelihood estimation to determine whether the 
covariates are significant or not. Several popular distributions on the survival data 
analysis as endorsed by graphical techniques were used. 
We applied the split exponential and the split Weibull models together with deviance 
test, a parametric test for the presence of immunes, and a test for outlier, to test for 
sufficient follow-up in the samples where there may or may not be immunes presences. 
We presented the probability of eventual immune for the ith individual as the logit 
model and logistic model. We will work with two data sets, firstly a Clinical Trial in the 
Treatment of Carcinoma of the Oropharynx and secondly Stanford Heart Transplant 
data. 
The results from the data analyses for a Clinical Trial in the Treatment of Carcinoma of 
the Oropharynx data show that the simple exponential model produces a fit not 
significantly worse than the simple Weibull model and the simple split Weibull model 
no better than the simple split exponential model, also shown that no evidence of 
immune population and all covariates are not significant. 
The results from the data analyses for Stanford Heart Transplant data show that the 
simple Weibull model is significantly better than the simple exponential model, and the 
simple split Weibull model is better than the simple split exponential model. We have 
calculated the maximum log-likelihood function value for both the logit exponential and 
logistic exponential models. They are exactly similar for both the Clinical Trial in the 
Treatment of Carcinoma of the Oropharynx and Stanford Heart Transplant data. So, we 
suggest that both the logit exponential and logistic exponential models are equally 
superior. 
PEMWTAKkAN SULTAN ABDUL SAMAD 
IJMVERSITI WTRA MALAYSlA 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Master Sains 
PENGGUNAAN MODEL TERPISAH EKSPONEN DAN WEIBULL PADA 
ANALISIS DATA HAYAT DENGAN MASA HAYAT LAMA 
Oleh 
DESI RAHMATINA 
Disember 2005 
Pengerusi: Profesor Madya Mohd Rizam bin Abu Bakar, PhD 
Fakulti : Sains 
Model populasi terpisah merupakan kaedah perluasan yang anjal dalam kaedah 
analisis hayat kepada data masa gaga1 dimana wujud dua kelompok individu iaitu 
peka dan kebal. Individu yang peka iaitu individu yang mengalami peristiwa ke atas 
kajian yang dibuat, manakala individu yang kebal iaitu individu yang tak pernah 
mengalami peristiwa ke atas kajian yang dibuat. 
Suatu kajian telah dibuat kepada kesan kovariat keatas kebarangkalian suatu individu 
kebal dan kebarangkalian kebal berubah dari individu ke individu. Kami 
menggabungkan dengan setiap individu kebarangkalian wujudnya kebal, yang 
bergantung kepada maklurnat kovariat khusus pada individu tersebut. Dan kemudian 
menggunakan beberapa model menggunakan anggaran kebolehjadian maksimum 
untuk menentukan sama ada kovariat bererti atau tidak. Beberapa taburan yang 
popular dalam analisis data hayat disokong oleh kaedah gambar darjah telahpun 
digunakan. 
Kami telah menggunakan model terpisah eksponen dan model terpisah Weibull 
bersamaan dengan ujian sisihan, ujian parameter kepada wujudnya kebal, dan satu 
ujian kepada data terpencil, untuk menguji kepada tindakan susulan dalam sampel 
dimana wujud atau tidak wujud kebal. Kami telah membentangkan kebarangkalian 
kebal kepada setiap individu dalarn model logit dan model logistik. Kami 
menggunakan dua kumpulan data iaitu data "Clinical Trial in the Treatment of 
Carcinoma of the Oropharynx " dan data "Stanford Heart Transplant". 
Keputusan daripada analisis data Clinical Trial in the Treatment of Carcinoma of the 
Oropharynx menunjukkan bahawa model simpel eksponen menghasilkan signifikan 
yang tidak lebih buruk dari model simpel Weibull dan model terpisah simpel Weibull 
tidak lebih baik dari model terpisah simple eksponen, juga ditunjukkan bahawa tidak 
terbukti populasi kebal dan semua kovariat adalah tidak bererti. 
Keputusan daripada analisis data Stanford Heart Transplant pulak menunjukkan 
bahawa model simpel Weibull menghasilkan signifikan lebih baik dari model simpel 
eksponen dan model terpisah simpel Weibull adalah lebih baik dari model terpisah 
simple eksponen. Kami telah mengira nilai bagi fungsi kebolehjadian maksimum 
kepada model logit eksponen dan model logistik eksponen. Nilai tersebut adalah 
sama bagi data Clinical Trial in the Treatment of Carcinoma of the Oropharynx dan 
data Stanford Heart Transplant. Jadi, kami menunjukkan bahawa model logit dan 
logistik model adalah serupa. 
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CHAPTER 1 
m-TRODUCTION 
I .I Split Population Models 
In standard survival analysis, data come in the form of faiIure times that are 
possibly censored, aIong with covariate information on each individual. It is 
also assumed that if complete foIIow-up were possible for all individual, each 
would eventually experience the event. Sometimes however, the failure time 
data come from a population where a substantial proportion of the inhviduals 
does not experience the event at the end of the observation period. In some 
situations, there is reason to believe that some of these survivors are actually 
"cured or "long-term survivors" the sense that even after an extended follow- 
up, no further events are observed on these individuals. Long-term survivors 
are those who are not subject to the event of interest. For example, in a medical 
study involving patients with a fatal disease, the patients would be expected to 
die of the disease sooner or later, and all deaths could be observed if the 
patients had been followed long enough. However, when considering endpoints 
other than death, the assumption may not be sustainable if long-term survivor 
are present in population. In contrast, the remaining individuals are at the risk 
of developing the event and therefore, they are called susceptibles. Examples in 
which long-term survivors exist can be found in many different areas. 
In the fieId of radiation research, patients with tumors of the neck and head are 
frequently treated with radiation. The endpoint of particular interest is local 
recurrence of the tumor. It has been observed that only between 5% and 50% of 
patients will experience local recurrences (Taylor, 1995). It is extremely 
unlikely, if not impossible, that local recurrences will occur later than 5 years 
after treatment. Therefore, the patients without experience of local recurrences 
within 5 years afier treatment may be treated as long-term survivors. 
In criminology, a criminologist may be interested in the probability that an 
indwidual will not return to prison after being released. If recidwism is the 
event of interest, many individuals who are released from prison will not 
experience the event because one experience of prison is sufficient (Maller and 
Zhou, 1996). 
Examples can be found even in engineering reliability (Meeker, 1987). Usually, 
the proportion of defective electronic components from a production process is 
assessed using a life testing procedure. Electronic components will fail the test 
if they have manufacturing defects, which cannot be detected in a simple 
inspection. Only a small fraction of electronic components have such defects. If 
a component is free of the defects, the chance that it will fail under carefully 
controlled condtions will be virtually zero. 
The above examples suggest that long-term survivor exist in the populations 
under study. However, the long-term survivors can never be identified and as 
the result of thls, they are manifested as censored observations in the data. 
Except those long-term survivors who withdraw from the study early and are 
censored at the time of their withdrawal, the remaining long-term survivors will 
be censored at the end of the study. Their large censored survival times will 
usually make the Kaplan-Meier estimate of the survival function level off at the 
right extreme, a Kaplan-Meier survival curve that levels off or shows a long 
and stable plateau is deemed to provide empirical evidence of a cured fraction. 
The use of standard survival analysis for such data would be inappropriate 
since not all of the long-term survivors can be considered as censored 
observations from the same population as those that do experience the event 
(Pierce, Stewart, and Kopecky, 1979; Farewell, 1982). 
Split population models are also known as "cure model". The objective of the 
cure model is to study the survival Qstribution and cure rate of such a 
population. In general term, we have an endpoint or event that we are interested 
in such as death from a specific cause, disease recurrence, or some other type of 
failure. The failure time or survival time is the time to the occurrence of such 
an event. In an individual we are interested in whether the event can occur 
which we shall call incidence, and when it will occur (given that it can occur) 
which we shall call conditional latency or simply latency. A cure would 
correspond to an event-flee outcome, and the cure rate would be one minus the 
incidence probability. As in standard survival analysis, we also want to study 
the effect of covariates on the outcome. An individua17s covariates can affect 
the incidence probability (more or less probability) andor the latency (earlier or 
later occurrence) and the effect of the covariates may be different on these two 
aspects of the outcome. 
Split population models in the biometrics literature, i.e., part of the population 
is cured and will never experience the event, and have both a long history (e-g. 
Boag 1949; Berkson and Gage 1952) and widespread applications and 
extensions in recent years (e.g.Farewel1 1982; Aden 1988; Kuk and Chen 
1992). The intuition behind these models is that, while standard duration 
models require a proper Qstribution for the density which makes up the hazard 
(i.e., one which integrates to one; in other words, that all subjects in the study 
will eventually fail), split population models allow for a subpopulation which 
never experiences the event of interest. This is typically accomplished through 
a mixture of a standard hazard density and a point mass at zero (Maller and 
Zhao 1996). That is, split population models estimate an additional parameter 
(or parameters) for the probability of eventual failure, which can be less than 
one for some portion of the data. In contrast, standard event history models 
assume that eventually all observations will fail, a strong and often unrealistic 
assumption. 
Suppose that F, (t) is the usual cumulative Qstribution function for recidivists 
only, and w is the probability of being subject to reconviction, h c h  is also 
usually known as the eventual recidwism rate. The probability of being 
immune is (1- w ), which is sometimes described as the rate of termination. This 
second group of immune individuals will never reoffend. Therefore their 
survival times are infinite (with probability one) and so their assow#& 
Ff3mJmM aTm Am t;#@4&@ 
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cumulative distribution function is identically zero, for all finite t > 0. If we 
now define Fs(t)=o FR(t), as the new cumulative distribution function of 
failure for the split-population, then this is an improper distribution, in the 
sense that, for 0 < o < 1, Fs(ao)= o< 1. 
Let X be an indicative variable, such that 
yi= { 0 ; ith individual will never fail (immunity) 
1 ;  ith individual will eventually fail (recrdivist) 
and follows the discrete probability distribution 
Pr[yi=l]=o 
and 
For any individual belonging to the group of recidivists, we define the density 
function of eventual failure as FR (t) with corresponding survival function 
S d ) ,  while for individual belonging to the other (immune) group, the density 
function of failure is identically zero and the survival function is identically 
one, for all finite time t. 
Suppose the conditional probability density function for those who will 
eventually fail (recidivists) is 
f(tIY = I ) =  fR(t)= ~ ; ( t )  
wherever FR ( t )  is differentiable. The unconditional probability density function 
of the failure time is given by 
f , ( t )= f(tI Y =O)Pr[Y =0]+ f ( t  IY =l)Pr[Y = 1 ]  
Similarly, the survival function for the recidivist group is defined as 
= J fR ( u ) ~ u  = 1 - FR (t). 
The unconditional survival time is then defined for the split population as 
which corresponds to the probability of being a long-term survivor plus the 
probability of being a recidivist who reoffends at some time beyond t. In this 
case, 
Fs (0 = OF' 0)  
is again an improper distribution function for w < 1. The likelihood fkxtim 
can then be written as 
and the log-likelihood function becomes 
where Si is an indicator of the censoring status of observation ti, and 0 is 
vector of all unknown parameters for f, (t) and S, (t) . The existence of these 
two types of release, one type that simply does not reoffend and another that 
eventually fails according to some distribution, leads to what may be described 
as simple split-population model. When we modify both fR (t) andSR (t) to 
include covariate effects, f, (t I z) and S, (t I z) respectively, then these will be 
referred to as split-population models. 
Several authors have fitted the model in Fs (t) = w FR (t) to recidivist data 
through various parametric forms of FR (t) . Schmidt and Witte (1988) consider 
a great number of possible parameterisations to model their North Carolina 
datasets, includmg the log-normal, the exponential and the Weibull 
distributions. They also consider "standard parametric survival model, i.e. 
when all individuals are assumed to be susceptibles (w =l). They find that all 
split-population models fit their data far better than the standard model. Rhodes 
(1989) and Farewell (1986), however, emphasize that, to use the split- 
population model, the dataset should be extensive enough to distinguish 
between desisters and persisters. 
